From scientific vision
to investment-grade
strategy.
I work fractionally with pre-Series A biotech and healthcare companies to build the financial models and commercial narratives that give investors and partners what they need to decide.
My career spans university technology transfer, corporate strategy at a public diagnostics company, and independent consulting — always at the intersection of science, finance, and commercial strategy. I work with founders who need senior-level thinking at a critical moment, without the full-time cost.
Where I can help.
Pro forma models and patient-based forecasts that clarify your business for investors and partners — grounded in primary research, not assumptions.
Delivered as documented, assumption-transparent models your team continues to use.
02Market sizing, payer discovery, and go-to-market planning grounded in what payers and providers actually say.
Delivered as usable playbooks and analyses, structured for your data room.
03From partnership search through term sheet, negotiation, and alliance management — with a proven track record at every scale.
Alliance structures and operating models built to run without me.